Seer to Present at the J.P. Morgan 43rd Annual Healthcare Conference

Company Participation - Seer, Inc. will participate in the J.P. Morgan 43rd Annual Healthcare Conference in San Francisco, CA [1] - The management is scheduled to present and engage in a Q&A session on January 15 at 3:00 p.m. Pacific Time [2] Product Overview - Seer is a life sciences company focused on developing transformative products for proteomics [3] - The Proteograph Product Suite includes engineered nanoparticles, consumables, automation instrumentation, and software for deep proteomic analysis [3] - The Proteograph workflow is designed to be efficient and user-friendly, allowing integration into various laboratory settings [3]